Abstract
The Alzheimer’s disease is considered a progressive cognitive disorder; however, several non-cognitive symptoms accompany all stages of the disease, appearing at times before the cognitive symptoms become manifest. This article reviews the literature on non-cognitive symptoms normally related to the Alzheimer’s disease, including gait and balance dysfunction, olfactory dysfunction, diabetes, pain, and psychiatric symptoms.
Similar content being viewed by others
References
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34:939–944
Alzheimer A (1907) Uber eine eigenartige Erkrankung der Hirnrinde. Allg Zeitschr Psychiatr 64:146–148
Braak H, Braak E (1995) Staging of Alzheimer’s disease-related neurofibrillary changes. Neurobiol Aging 16:271–284
Braak H, Thalam DR, Ghebremedhin E, Del Tredici K (2011) Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70:960–969
Saito Y, Murayama S (2000) Expression of tau immunoreactivity in the spinal motor neurons of Alzheimer’s disease. Neurology 55:1727–1729
Schmidt ML, Zhukareva V, Perl DP, Sheridan SK, Schuck T, Lee VMY, Trjanowskj JQ (2001) Spinal cord neurofibrillary pathology in Alzheimer disease and Guam Parkinsonism-dementia complex. J Neuropathol Exp Neurol 60:1075–1086
Miklossy J, Taddei K, Martins R, Escher G, Kraftsik R, Pillevuit O, Lepori D, Campiche M (1999) Alzheimer disease: curly fibers and tangles in organs other than brain. J Neuropathol Exp Neurol 58:803–814
Wirths O, Weis J, Szczygielski J, Multhaup G, Bayer TA (2006) Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer’s disease. Acta Neuropathol 111:312–319
Filali M, Lalonde R, Rivest S (2009) Cognitive and non-cognitive behaviors in an APPswe/PS1 bigenic model of Alzheimer’s disease. Genes Brain Behav 8:143–148
Pugh PL, Richardson JC, Bate ST, Upton N, Sunter D (2007) Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer’s disease. Behav Brain Res 178:18–28
Hl Klawans, Tufo HM, Ostfeld AM, Shekelle RB, Kilbridge JA (1971) Neurologic examination in an elderly population. Dis Nerv Syst 32:274–279
Gleason CE, Gangnon RE, Fisher BL, Mahoney JE (2009) Increased risk for falling associated with subtle cognitive impairment: secondary analysis of a randomized clinical trial. Dement Geriatr Cogn Disord 27:557–563
Thomas VS, Vandenberg EV, Potter JF (2002) Non-neurological factors are implicated in impairments in gait and mobility among patients in a clinical dementia referral population. Int J Geriatr Psychiatry 17:128–133
Van Schoor NM, Smit JH, Pluijm SMF, Jonker C, Lips P (2002) Different cognitive functions in relation to falls among older persons. Immediate memory as an independent risk factor for falls. J Clin Epidemiol 55:855–862
Naslund J (2010) Visuospatial ability in relation to fall risk and dementia. Arch Neurol 67:643–644
Verghese J, Wang C, Lipton RB, Holtzer R, Xue X (2007) Quantitative gait dysfunction and risk of cognitive decline and dementia. J Neurol Neurosurg Psychiatry 78:929–935
Kotagal V, Muller ML, Kaufer DI, Koeppe RA, Bohnen NI (2012) Thalamic cholinergic innervation is spared in Alzheimer disease compared to parkinsonian disorders. Neurosci Lett 514:169–172
Jolivalt CG, Calcutt NA, Masliah E (2012) Similar pattern of peripheral neuropathy in mouse models of type 1 diabetes and Alzheimer’s disease. Neuroscience 202:405–412
Nousiainen U, Partanen J, Koivisto K, Soininen H, Riekkinen PJ (1991) Electroneuromyographic findings in patients with Alzheimer’s disease. Electromyogr Clin Neurophysiol 31:119–122
Waldton S (1974) Clinical observations of impaired cranial nerve function in senile dementia. Acta Psychiatr Scand 50:539–547
Rezek DJ (1987) Olfactory deficits as a neurologic sign in dementia of Alzheimer type. Arch Neurol 44:1030–1103
Berthoud HR (2011) Metabolic and hedonic drives in the neural control of appetite: who is the boss? Curr Opin Neurobiol 21:888–896
Thompson MD, Knee K, Golden CJ (1998) Olfaction in persons with Alzheimer’s disease. Neuropsychol Review 8:11–23
Mesholam RI, Moberg PJ, Mahr RN, Doty RL (1998) Olfaction in neurodegenerative disease. A meta-analysis of olfactory functioning in Alzheimer’s and Parkinson’s diseases. Arch Neurol 55:84–90
Devanand DP, Liu X, Tabert MH, Pradhaban G, Cuasay K, Bell K, de Leon MJ, Doty RL, Stern Y, Pelton GH (2008) Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer’s disease. Biol Psychiatry 64:871–879
Forster S, Vaitl A, Teipel SJ, Yakushev I, Mustafa M, la Fougere C, Rominger A, Cumming P, Bartenstein P, Hampel H, Hummel T, Buerger K, Hundt W, Steinbach S (2010) Functional representation of olfactory impairment in early Alzheimer’s disease. J Alzheimers Dis 22:581–591
Wilson RS, Arnold SE, Schneider JA, Tang Y, Bennet DA (2007) The relationship between cerebral Alzheimer’s disease pathology and odour identification in old age. J Neurol Neurosurg Psychiatry 78:30–35
Bahar-Fuchs A, Chetelat G, Villemagne VL, Moss S, Pike K, Mastes CL, Rowe C, Savage G (2000) Olfactory deficits and amyloid-β burden in Alzheimer’s disease, mild cognitive impairment, and healthy aging: a PiB PET study. J Alzheimers Dis 22:1081–1087
Li W, Howard JD, Gottfried JA (2010) Disruption of odour quality coding in piriform cortex mediates olfactory deficits in Alzheimer’s disease. Brain 133:2714–2726
Wesson DW, Borkowski AH, Landreth GE, Nixon RA, Levy E, Wilson DA (2011) Sensory network dysfunction, behavioral impairments, and their reversibility in an Alzheimer’s β-amyloidosis mouse model. J Neurosci 31:15962–15971
Murphy C, Bacon AW, Bondi MW, Salmon DP (1998) Apolipoprotein E status is associated with odor identification deficits in nondemented older persons. Ann NY Acad Sci 855:744–750
Pickering G, Jourdan D, Dubray C (2005) Acute versus chronic pain treatment in Alzheimer’s disease. Eur J Pain 10:379–384
Pickering G, Eschalier A, Dubray C (2000) Pain and Alzheimer’s disease. Gerontology 46:235–241
Benedetti F, Arduino C, Costa S, Vighetti S, Tarenzi L, Rainero I, Asteggiano G (2006) Loss of expectation-related mechanisms in Alzheimer’s disease makes analgesic therapies less effective. Pain 121:133–144
Cole LJ, Gravilescu M, Johnston LA, Gibson SJ, Farrell MJ, Egan GF (2011) The impact of Alzheimer’s disease on the functional connectivity between brain regions underlying pain perception. Eur J Pain 15:568e1–568e11
Monastero R, Mangialasche R, Camarda C, Ercolani S, Camarda SA (2009) A systematc review of neuropsychiatric symptoms in mild cognitive impairment. J Alzheimers Dis 18:11–30
Gonfrier S, Andrieu S, Renaud D, Vellas B, Robert PH (2012) Course of neuropsychiatric symptoms during a 4-years follow up in the REAL-FR cohort. J Nutr Health Aging 16:134–137
Rozzini L, Vicini Chilovi B, Conti M, Delro I, Borrono B, Trabucchi M, Padovani A (2008) Neuropsychiatric symptoms in amnestic and nonamnestic mild cognitive impairment. Dement Geriatr Cogn Disord 25:32–36
Ownby RL, Crocco E, Acevedo A, John V, Lowenstein D (2006) Depression and risk for Alzheimer’s disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 63:530–538
Byers AL, Yaffe K (2011) Depression and risk of developing dementia. Nat Rev Neurol 7:323–331
Royall DR, Palmer R, Chiodo LK, Polk MJ (2012) Depressive symptoms predict longitudinal change in executive control but not memory. Int J Geriatr Psychiatry 27:89–96
Palmer K, Di Iulio F, Varsi AE, Gianni W, Sancesario G, Caltagirone C, Spalletta G (2010) Neuropsychiatric predictors of progression from amnestic-mild cognitive impairment to Alzheimer’s disease: the role of depression and apathy. J Alzheimers Dis 20:175–183
Fernandez-Martinez M, Molano A, Castro J, Zarranz JJ (2010) Prevalence of neuropsychiatric simptoms in mild cognitive impairment and Alzheimer’s disease, and its relationship with cognitive impairment. Curr Alzheimer Res 7:517–526
Tsopelas C, Stewart R, Savva GM, Brayne C, Ince P, Thomas A, Matthews FE (2011) Medical research council cognitive function and ageing study. Neuropathological correlates of late-life depression in older people. Br J Psychiatry 198:104–109
Rubio A, Vestner AL, Stewart JM, Forbes NT, Conwell Y, Cox C (2001) Suicide and Alzheimer’s pathology in the elderly: a case-control study. Biol Psychiatry 49:137–145
Peisah C, Snowdon J, Gorrie C, Kril J, Rodriguez M (2007) Investigation of Alzheimer’s disease-related pathology in community dwelling older subjects who committed suicide. J Affect Disord 99:127–132
Ropacki SA, Jeste DV (2005) Epidemiology of and risk factors for psychosis of Alzheimer’s disease: a review of 55 studies published from 1990 to 2003. Am J Psychiatry 162:2022–2030
Leroi I, Voulgari A, Breiner JC, Lyketsos CG (2003) The epidemiology of psychosis in dementia. Am J Geriatr Psychiatry 11:83–91
Lyketsos C, Breitner JCS, Rabins PV (2001) An evidence-based proposal for the classification of neuropsychiatric disturbance in Alzheimer’s disease. Int J Geriatr Psychiatry 16:1037–1042
Aalten P, Verhey FR, Boziki M, Bullock R, Byrne EJ, Camus V, Caputo M, Collins D, De Deyn PP, Elina K, Frisoni G, Girtler N, Holmes C, Hurt C, Marriott A, Mecocci P, Nobili F, Ousset PJ, Reynish E, Salmon E, Tsolaki M, Vellas B, Robert PH (2007) Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part I. Dement Geriatr Cogn Disord 24:457–463
Taragano FE, Allegri RF, Krupitzki H, Sarasola D, Serrano CM, Lon L, Lyketsos CG (2009) Mild behavioral impairment and risk of dementia. J Clin Psychiatry 70:584–592
Pietropaolo S, Delage P, Lebtreton F, Crusio WE, Cho YH (2010) Early development of social deficits in APP and APP-PS1 mice. Neurobiol Aging 33:1002e17–1003e27
Archin S, Mahendra N (2001) Insight in Alzheimer’s patients: results of a longitudinal study using three assessment methods. Am J Alzheimers Dis Other Dem 16:211–224
Kobayashi T, Kato S (2011) Depression-dementia medius: between depression and the manifestation of dementia symptoms. Psychogeriatrics 11:177–182
Wuwongse S, Chang RCC, Law ACK (2010) The putative neurodegenerative links between depression and Alzheimer’s disease. Progress Neurobiol 91:362–375
Kang JY, Lee JS, Kang H, Lee HW, Kim YK, Jeon HJ, Chung JK, Lee MC, Cho MJ, Lee DS (2012) Regional cerebral blood flow abnormalities associated with apathy and depression in Alzheimer disease. Alzheimer Dis Assoc Disord 26:217–224
Kramberger MG, Jelic V, Kareholt I, Enache D, Jonhagen ME, Winblad B, Aarsland D (2012) Cerebrospinal fluid Alzheimer markers in depressed elderly subjects with and without Alzheimer’s disease. Dement Geriatr Cogn Disord Extra 2:48–56
Cheng G, Huang C, Wang H (2012) Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Int Med J 42:489–491
Messier C (2003) Diabetes, Alzheimer’s disease and apolipoprotein genotype. Exp Gerontol 38:941–946
Craft S, Asthana S, Newcomer JW, Wilkinson CV, Matos IT, Baker LD, Cherrier M, Lofgreen C, Latendresse S, Petrova A, Plymate S, Raskind M, Grimwood K, Veit RC (1999) Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose. Arch Gen Psychiatry 56:1135–1140
Marks DR, Tucker K, Cavallin MA, Mast TG, Fadool DA (2009) Awake intranasal insulin delivery modifies protein complexes and alters memory, anxiety, and olfactory behaviors. J Neurosci 29:6734–6751
Alafuzoff I, Aho L, Helisalmi S, Mannermaat A, Soininen H (2009) β-amyloid deposition in brains of subjects with diabetes. Neuropathol Appl Neurobiol 35:60–68
Miklossy J, Quing H, Radenovic A, Kis A, Vileno B, Laszlo F, Miller L, Martins RN, Waeber G, Mooser V, Bosman F, Khalili K, Darbinian N, McGeer PL (2010) Beta amyloid and hyperphosphorilated tau deposits in the pancreas in type 2 diabetes. Neurobiol Aging 31:1503–1515
Burdo JR, Chen Q, Calcutt NA, Schubert D (2009) The pathological interaction between diabetes and presymptomatic Alzheimer’s disease. Neurobiol Aging 30:1910–1917
Takeda S, Sato N, Uchio-Yamada K, Sawada K, Kunieda T, Takeuchi D, Kurinami H, Shinohara M, Rakugi H, Morishita R (2010) Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in an Alzheimer mouse model with diabetes. PNAS 107:7036–7041
Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR, de la Monte SM (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease- is this type 3 diabets? J Alzheimers Dis 7:63–80
Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucki A, Fuino RL, Kawaguchi KR, Samoyedny AJ, Wilson RS, Arvanitakis Z, Schneider JA, Wolf BA, Bennet DA, Trojanowski JQ, Arnold SE (2012) Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 122:1316–1338
Bomfim TR, Forny-Germano L, Sathler LB, Brito-Moreira J, Houzel JC, Decker H, Silverman MA, Kazi H, Melo HM, McClean PL, Holscher C, Arnold SE, Talbot K, Klein WL, Munoz DP, Ferreira ST, De Felice FG (2012) An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease-associated Aβ oligomers. J Clin Invest 122:1339–1353
Smith MA, Petot GJ, Perry G (1999) Diet and oxidative stress: a novel synthesis of epidemiological data on Alzheimer’s disease. J Alzheimers Dis 1:203–206
Ewald CY, Raps DA, Li C (2012) APL-1, the Alzheimer’s amyloid precursor protein in Caenorhabditis elegans, modulates multiple metabolic pathways throughout development. Genetics 191:493–507
Sperling RA, Aisen PS, Beckett AL, Bennet DA, Craft S, Fagan AM, Iwatsubo T, Jack CR, Kaye J, Montine TJ, Park DC, Reiman EM, Rowe CC, Siemers E, Stern Y, Yaffe K, Carillo MC, Thies B, Morrison-Bogorad M, Wagster MV, Phelps CH (2011) Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute of Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:280–292
Langston JW (2006) The Parkinson’s complex: parkinsonism is just the tip of the iceberg. Ann Neurol 59:591–596
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Raudino, F. Non-cognitive symptoms and related conditions in the Alzheimer’s disease: a literature review. Neurol Sci 34, 1275–1282 (2013). https://doi.org/10.1007/s10072-013-1424-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-013-1424-7